Medidata Solutions Inc (MDSO) : First Mercantile Trust Co reduced its stake in Medidata Solutions Inc by 18.76% during the most recent quarter end. The investment management company now holds a total of 30,810 shares of Medidata Solutions Inc which is valued at $1,719,506 after selling 7,113 shares in Medidata Solutions Inc , the firm said in a disclosure report filed with the SEC on Oct 7, 2016.Medidata Solutions Inc makes up approximately 0.23% of First Mercantile Trust Co’s portfolio.
Other Hedge Funds, Including , Simplex Trading added MDSO to its portfolio by purchasing 1,662 company shares during the most recent quarter which is valued at $92,756. Medidata Solutions Inc makes up approx 0.01% of Simplex Trading’s portfolio.Bnp Paribas Arbitrage Sa reduced its stake in MDSO by selling 9,393 shares or 52.65% in the most recent quarter. The Hedge Fund company now holds 8,448 shares of MDSO which is valued at $475,707. Eqis Capital Management sold out all of its stake in MDSO during the most recent quarter. The investment firm sold 6,228 shares of MDSO which is valued $350,699.
Medidata Solutions Inc opened for trading at $55.48 and hit $55.94 on the upside on Friday, eventually ending the session at $55.81, with a gain of 0.59% or 0.33 points. The heightened volatility saw the trading volume jump to 2,63,728 shares. Company has a market cap of $3,208 M.
On the company’s financial health, Medidata Solutions Inc reported $0.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Jul 20, 2016. Analyst had a consensus of $0.23. The company had revenue of $114.60 million for the quarter, compared to analysts expectations of $112.38 million. The company’s revenue was up 16.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.22 EPS.
Many Wall Street Analysts have commented on Medidata Solutions Inc. Medidata Solutions Inc was Downgraded by Wells Fargo to ” Market Perform” on Jul 21, 2016. Needham Resumed Medidata Solutions Inc on Jul 11, 2016 to “Buy”, Price Target of the shares are set at $55.
Medidata Solutions Inc. (Medidata) provides cloud-based solutions for life sciences. The Company’s solutions are Medidata Rave an electronic data capture (EDC) and clinical data management system (CDMS) solution; Medidata CTMS a clinical trial management solution; Medidata Designer a protocol design tool; Medidata Insights which offer clinical business analytics and metrics; Medidata Balance a randomization and trial supply management solution; Medidata Patient Cloud an electronic patient-reported outcome (ePRO) application; Medidata Grants Manager which develops and manages trial budgets; Medidata contract research organizations (CRO) Contractor an analytics tool; Medidata SQM a set of cloud-based site quality management dashboards; Medidata Coder a medical coding and synonym management solution; Medidata Safety Gateway which collects and transmits events and related data from the EDC system and Medidata Targeted SDV which implements risk-based monitoring strategies.